Global Citicoline Market Growth 2025-2031

Global Citicoline Market Growth 2025-2031

The global Citicoline market size is predicted to grow from US$ 378 million in 2025 to US$ 872 million in 2031; it is expected to grow at a CAGR of 14.9% from 2025 to 2031.

Citicoline (cytidine diphosphocholine, CDP-choline) is a novel nutrient with a broad spectrum of benefits for conditions associated with symptoms of neurological dysfunction. An endogenous compound, citicoline is an essential intermediate in the synthesis of cell membrane phospholipids and its formation is the rate-limiting step in phosphatidylcholine synthesis. It plays several important roles in human physiology, including enhancement of structural integrity and signaling for cell membranes, support of acetylcholine synthesis, and synthesis of betaine, a methyl donor. Citicoline provides the brain with a source of choline and cytidine, which are efficiently used in the Kennedy cycle to generate phospholipids. It is able to attenuate the production of free radicals in ischemic conditions, while it also stimulates glutathione synthesis and the activity of glutathione reductase. Studies in animals and humans provide evidence of citicoline’s ability to promote learning and memory and improve cognitive impairment in Alzheimer’s and Parkinson’s disease, as well as in victims of mild to moderate stroke and cerebral ischemia. Citicoline administration may also reduce the duration of coma and the severity of mental and motor deficits associated with traumatic head injuries.

As a medicine, it is taken by mouth as a supplement or given by IV or as a shot. Citicoline is used for Alzheimer"s disease and other types of dementia, head trauma, cerebrovascular disease such as stroke, age-related memory loss, Parkinson"s disease, attention deficit-hyperactive disorder (ADHD), and glaucoma.

Citicoline was originally developed in Japan for stroke. It was later introduced as a prescription drug in many European countries. In these countries it is now frequently prescribed for thinking problems related to circulation problems in the brain. In the US, citicoline is marketed as a dietary supplement.

Global Citicoline key players include Union Korea Pharm, Century Pharma, Invision Medi Sciences, etc.

In terms of application, the largest application is Pharma, with a share over 85%, followed by Non-pharma.

LP Information, Inc. (LPI) ' newest research report, the “Citicoline Industry Forecast” looks at past sales and reviews total world Citicoline sales in 2024, providing a comprehensive analysis by region and market sector of projected Citicoline sales for 2025 through 2031. With Citicoline sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Citicoline industry.

This Insight Report provides a comprehensive analysis of the global Citicoline landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Citicoline portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Citicoline market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Citicoline and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Citicoline.

This report presents a comprehensive overview, market shares, and growth opportunities of Citicoline market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Injection
Tablets
Capsule

Segmentation by Application:
Pharma
Non-pharma

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Union Korea Pharm
Century Pharma
Invision Medi Sciences
Rasco Life Sciences
RPG Life Sciences Ltd
Chemo Biological
Harbin Pharm. Group Sanjing Pharmaceutical
Innova

Key Questions Addressed in this Report

What is the 10-year outlook for the global Citicoline market?

What factors are driving Citicoline market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Citicoline market opportunities vary by end market size?

How does Citicoline break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more